0001192482-20-000846.txt : 20201222
0001192482-20-000846.hdr.sgml : 20201222
20201222195335
ACCESSION NUMBER: 0001192482-20-000846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCP Vitalife Partners (Israel) II, L.P.
CENTRAL INDEX KEY: 0001602484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 201409475
BUSINESS ADDRESS:
STREET 1: 32B HABARZEL STREET
STREET 2: RAMAT HACHAYAL
CITY: TEL AVIV
STATE: L3
ZIP: 69710
BUSINESS PHONE: 610-995-2900
MAIL ADDRESS:
STREET 1: SUITE 190
STREET 2: 7 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-12-18
0001588972
Recro Pharma, Inc.
REPH
0001602484
SCP Vitalife Partners (Israel) II, L.P.
490 LAPP ROAD
MALVERN
PA
19355
0
0
1
0
Common Stock
2020-12-18
4
S
0
6208
3.0304
D
719847
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.03 to $3.035, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
/s/ Ryan Lake, Attorney-in-fact
2020-12-22